Detlev Boison Selected Research

Adenosine (Adenocard)

1/2022	ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain.
1/2021	The Good, the Bad, and the Deadly: Adenosinergic Mechanisms Underlying Sudden Unexpected Death in Epilepsy.
1/2021	ATP and adenosine-Two players in the control of seizures and epilepsy development.
1/2021	Adenosine kinase is critical for neointima formation after vascular injury by inducing aberrant DNA hypermethylation.
1/2021	Suppression of phrenic nerve activity as a potential predictor of imminent sudden unexpected death in epilepsy (SUDEP).
10/2020	Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia.
6/2020	Role of Adenosine in Epilepsy and Seizures.
1/2020	Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia.
1/2020	Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.
1/2020	Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Detlev Boison Research Topics

Disease

58	Epilepsy (Aura) 03/2022 - 08/2002
50	Seizures (Absence Seizure) 07/2022 - 08/2002
14	Gliosis 10/2020 - 01/2004
10	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021 - 10/2005
10	Schizophrenia (Dementia Praecox) 10/2020 - 03/2006
8	Drug Resistant Epilepsy 07/2022 - 07/2003
8	Neoplasms (Cancer) 01/2022 - 01/2012
8	Temporal Lobe Epilepsy 01/2020 - 07/2003
5	Inflammation (Inflammations) 01/2021 - 09/2011
5	Partial Epilepsies (Epilepsy, Partial) 01/2020 - 05/2005
5	Cognitive Dysfunction 01/2017 - 07/2008
4	Brain Injuries (Brain Injury) 01/2016 - 01/2010
4	Neurobehavioral Manifestations 12/2015 - 03/2006
3	Sudden Unexpected Death in Epilepsy 01/2021 - 03/2010
3	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2020 - 04/2016
3	Hypoxia (Hypoxemia) 01/2020 - 04/2016
3	Chronic Pain 01/2017 - 02/2008
3	Disease Progression 12/2015 - 03/2008
3	Brain Ischemia (Cerebral Ischemia) 07/2011 - 05/2007
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2011 - 05/2007
3	Stroke (Strokes) 07/2011 - 12/2006
2	Thrombosis (Thrombus) 01/2022 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 04/2014
2	Wounds and Injuries (Trauma) 03/2020 - 01/2017
2	Apnea 03/2020 - 03/2012
2	Brain Diseases (Brain Disorder) 01/2020 - 01/2011
2	Infections 01/2020 - 07/2011
2	Hippocampal Sclerosis 01/2019 - 09/2011
2	Hearing Loss (Hearing Impairment) 01/2017 - 11/2011
2	Autistic Disorder (Autism) 01/2017 - 01/2013
2	Nervous System Diseases (Neurological Disorders) 01/2013 - 07/2011
2	Infarction (Infarctions) 07/2011 - 05/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2010 - 12/2007
2	Ischemia 01/2008 - 01/2007
1	Amyloidosis 01/2022
1	Facial Pain (Myofacial Pain) 09/2021
1	Pain (Aches) 01/2021
1	Vascular System Injuries 01/2021
1	Neointima 01/2021
1	Atrophy 01/2020
1	COVID-19 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Body Weight (Weight, Body) 03/2019

Drug/Important Bio-Agent (IBA)

76	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 05/2002
35	Adenosine KinaseIBA 03/2022 - 01/2004
14	Anticonvulsants (Antiepileptic Drugs)IBA 01/2017 - 08/2003
11	EnzymesIBA 01/2022 - 01/2004
9	Kainic Acid (Kainate)IBA 01/2021 - 07/2003
7	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021 - 03/2008
7	CarbohydratesIBA 11/2020 - 07/2011
6	Adenosine A1 ReceptorIBA 03/2022 - 07/2003
6	Neurotransmitter Agents (Neurotransmitter)IBA 10/2020 - 05/2007
6	Glutamic Acid (Glutamate)FDA Link 10/2020 - 08/2003
6	Caffeine (No Doz)FDA LinkGeneric 03/2020 - 03/2010
6	Glycine Plasma Membrane Transport ProteinsIBA 01/2020 - 07/2008
5	Pharmaceutical PreparationsIBA 01/2021 - 07/2003
4	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2018
4	purineIBA 01/2022 - 01/2016
4	Adenosine Triphosphate (ATP)IBA 01/2022 - 12/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2013
4	Dopamine (Intropin)FDA LinkGeneric 10/2020 - 03/2012
4	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 06/2020 - 09/2002
4	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020 - 03/2006
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 04/2013 - 03/2006
3	Neuroprotective AgentsIBA 01/2021 - 05/2007
3	Proteins (Proteins, Gene)FDA Link 10/2020 - 09/2011
3	Therapeutic UsesIBA 01/2020 - 05/2007
3	Silk FDA Link 09/2009 - 09/2006
2	5'-Nucleotidase (5' Nucleotidase)IBA 03/2022 - 08/2015
2	Protein Isoforms (Isoforms)IBA 04/2021 - 01/2016
2	NucleosidesIBA 01/2020 - 01/2011
2	Antipsychotic Agents (Antipsychotics)IBA 04/2013 - 05/2011
2	Purinergic P1 Receptor AntagonistsIBA 03/2012 - 01/2011
2	PolymersIBA 08/2009 - 09/2008
1	Adenosine Diphosphate (ADP)IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	5-methyldeoxycytidineIBA 04/2021
1	Platelet-Derived Growth FactorIBA 01/2021
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2020
1	Histones (Histone)IBA 01/2020
1	Equilibrative Nucleoside Transporter 1IBA 01/2020
1	Adenosine DeaminaseIBA 01/2020
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 03/2019
1	CarcinogensIBA 03/2019
1	Phenobarbital (Luminal)FDA Link 03/2019
1	AntibodiesIBA 01/2018
1	Isoflurane FDA LinkGeneric 01/2018
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2018
1	Losartan (Cozaar)FDA LinkGeneric 01/2018
1	AlbuminsIBA 01/2018

Therapy/Procedure

33	Therapeutics 07/2022 - 02/2005
7	Ketogenic Diet 11/2020 - 07/2011
4	Drug Therapy (Chemotherapy) 03/2012 - 12/2007
2	Transplantation 08/2009 - 04/2009
1	Injections 07/2022
1	Deep Brain Stimulation 07/2022
1	Vagus Nerve Stimulation 03/2022
1	Topical Administration 01/2018